Emerging studies showed the dysregulated CBX members in multiple cancer types, including ovarian cancer [13], cervical cancer [14], pancreatic cancer [15], lung cancer [16], liver cancer [17], esophageal squamous cell carcinoma [18], breast cancer [19, 20] and gastric cancer [21] and so on. This evidence concerns the gene CBX1 and cancer.